BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

115 related articles for article (PubMed ID: 2861323)

  • 21. Chronic granulomatous disease.
    Schmalzer EA; Miller DR
    Prog Med Genet; 1976; 1():145-84. PubMed ID: 935507
    [No Abstract]   [Full Text] [Related]  

  • 22. The respiratory burst of phagocytes.
    Babior BM
    J Clin Invest; 1984 Mar; 73(3):599-601. PubMed ID: 6323522
    [No Abstract]   [Full Text] [Related]  

  • 23. Chronic granulomatous disease: mutations in cytochrome b558.
    Roos D; De Boer M; De Klein A; Bolscher BG; Weening RS
    Immunodeficiency; 1993; 4(1-4):289-301. PubMed ID: 8167720
    [No Abstract]   [Full Text] [Related]  

  • 24. Structure of the NADPH-oxidase: membrane components.
    Segal AW
    Immunodeficiency; 1993; 4(1-4):167-79. PubMed ID: 8167695
    [No Abstract]   [Full Text] [Related]  

  • 25. Molecular genetics of chronic granulomatous disease.
    Dinauer MC; Orkin SH
    Immunodefic Rev; 1988; 1(1):55-69. PubMed ID: 3078710
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Steps toward an understanding of chronic granulomatous disease.
    Karnovsky ML
    N Engl J Med; 1983 Feb; 308(5):274-5. PubMed ID: 6848940
    [No Abstract]   [Full Text] [Related]  

  • 27. Chronic granulomatous disease.
    Babior BM; Woodman RC
    Semin Hematol; 1990 Jul; 27(3):247-59. PubMed ID: 2197728
    [No Abstract]   [Full Text] [Related]  

  • 28. Point mutation in the cytoplasmic domain of the neutrophil p22-phox cytochrome b subunit is associated with a nonfunctional NADPH oxidase and chronic granulomatous disease.
    Dinauer MC; Pierce EA; Erickson RW; Muhlebach TJ; Messner H; Orkin SH; Seger RA; Curnutte JT
    Proc Natl Acad Sci U S A; 1991 Dec; 88(24):11231-5. PubMed ID: 1763037
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Chronic granulomatous disease due to a defect in the cytosolic factor required for nicotinamide adenine dinucleotide phosphate oxidase activation.
    Curnutte JT; Berkow RL; Roberts RL; Shurin SB; Scott PJ
    J Clin Invest; 1988 Feb; 81(2):606-10. PubMed ID: 3339133
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Molecular genetic analysis of phagocyte oxidase cytochrome b558 mutations leading to chronic granulomatous disease.
    Hossle JP; Berthet F; Erny C; Seger RA
    Immunodeficiency; 1993; 4(1-4):303-6. PubMed ID: 8167722
    [No Abstract]   [Full Text] [Related]  

  • 31. NADPH-binding component of the respiratory burst oxidase system: studies using neutrophil membranes from patients with chronic granulomatous disease lacking the beta-subunit of cytochrome b558.
    Tsunawaki S; Mizunari H; Namiki H; Kuratsuji T
    J Exp Med; 1994 Jan; 179(1):291-7. PubMed ID: 8270871
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Cytofluorometric assessment of phagosomal oxidation and the mode of inheritance in patients suffering from chronic granulomatous disease.
    Kohl A; Roesler J; Döcke WD; Valet G; Volk HD
    Agents Actions; 1991 Jan; 32(1-2):134-6. PubMed ID: 2058461
    [No Abstract]   [Full Text] [Related]  

  • 33. [Biological and clinical aspects of chronic granulomatous disease].
    Robak T; Robak E
    Przegl Lek; 1992; 49(5):168-71. PubMed ID: 1438921
    [No Abstract]   [Full Text] [Related]  

  • 34. Cytochrome b deficiency in an autosomal form of chronic granulomatous disease. A third form of chronic granulomatous disease recognized by monocyte hybridization.
    Weening RS; Corbeel L; de Boer M; Lutter R; van Zwieten R; Hamers MN; Roos D
    J Clin Invest; 1985 Mar; 75(3):915-20. PubMed ID: 3980731
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Oxidants from phagocytes: agents of defense and destruction.
    Babior BM
    Blood; 1984 Nov; 64(5):959-66. PubMed ID: 6386073
    [No Abstract]   [Full Text] [Related]  

  • 36. Autosomal recessive chronic granulomatous disease caused by deletion at a dinucleotide repeat.
    Casimir CM; Bu-Ghanim HN; Rodaway AR; Bentley DL; Rowe P; Segal AW
    Proc Natl Acad Sci U S A; 1991 Apr; 88(7):2753-7. PubMed ID: 2011585
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Genetic heterogeneity in patients with X-linked recessive chronic granulomatous disease.
    Ariga T; Nakanishi M; Tomizawa K; Imajoh-Ohmi S; Kanegasaki S; Sakiyama Y; Matsumoto S
    Pediatr Res; 1992 May; 31(5):516-9. PubMed ID: 1603631
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Characterization of 11 novel mutations in the X-linked chronic granulomatous disease (CYBB gene).
    Gérard B; El Benna J; Alcain F; Gougerot-Pocidalo MA; Grandchamp B; Chollet-Martin S
    Hum Mutat; 2001 Aug; 18(2):163. PubMed ID: 11462241
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Absence of both cytochrome b-245 subunits from neutrophils in X-linked chronic granulomatous disease.
    Segal AW
    Nature; 1987 Mar 5-11; 326(6108):88-91. PubMed ID: 3821877
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Genetic variants of chronic granulomatous disease: prevalence of deficiencies of two cytosolic components of the NADPH oxidase system.
    Clark RA; Malech HL; Gallin JI; Nunoi H; Volpp BD; Pearson DW; Nauseef WM; Curnutte JT
    N Engl J Med; 1989 Sep; 321(10):647-52. PubMed ID: 2770793
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 6.